NantHealth’s Vitality Mobile App Now Available on Apple and Android Devices
25 October 2017 - 10:00PM
Business Wire
Vitality® GlowCap®, an industry leading smart
pill bottle, has been proven to be effective for improving
medication adherence
NantHealth, Inc. (NASDAQ-GS: NH), a next-generation,
evidence-based, personalized healthcare company, today announced
that its Vitality Mobile app is now available for download through
the Apple and Google Play Stores. When linked with Vitality
GlowCap, Vitality Mobile delivers users a comprehensive mobile
experience for tracking and improving medication adherence.
NantHealth will be showcasing the Vitality medication adherence
system at booth 102 at the Connected Health Conference, hosted by
the Personal Connected Health Alliance, in Boston at the Seaport
World Trade Center from October 25-27, 2017.
Vitality GlowCap is a smart pill bottle that offers automated
visual and audible alerts during scheduled medication dosage
windows that signal when it is time for the user to take his or her
medications. With the new Vitality Mobile app, users can link their
mobile device to a Vitality GlowCap to view and track their
medication adherence in near-real time. Additionally, users may
give their clinicians, care managers and family members access to
their adherence information, allowing for buddy reminders and
social support.
“Medication nonadherence is a major public health concern that
not only affects patient outcomes, but is also costing the overall
healthcare industry $100-300 billion a year1,” said Patrick
Soon-Shiong, MD, CEO and founder of NantHealth. “Vitality GlowCap
is effective for medication adherence, proven through a
peer-reviewed study with Partners Healthcare, Massachusetts General
Hospital and Harvard Medical School. Today’s launch of the Vitality
Mobile app is another step forward in tackling the issue of
medication nonadherence, empowering patients to actively
participate in improving their health.”
In a peer-reviewed study conducted with Partners HealthCare –
The Center for Connected Health, Massachusetts General Hospital,
and Harvard Medical School, audio and visual reminders from the
Vitality system were proven to be effective in improving medication
adherence. Among study participants, 86 percent of subjects who
used Vitality reminders achieved an overall 80 percent medication
adherence rate, compared to only 45 percent of subjects meeting
that rate without the Vitality reminders.
In addition to providing patients an easy and sustainable way to
manage their own medications, the Vitality medication adherence
system, comprised of GlowCap and Vitality Mobile, is also useful
for hospitals and health systems, pharmacies, accountable care
organizations, health insurers, wellness providers and clinical
trial sponsors. Specifically, Vitality Mobile can assist
pharmaceutical companies, contract research organizations and
hospitals in tracking the frequency that their participants are
taking medication – which is required for successful studies.
Cautionary Note Concerning Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995, including, among others, statements regarding the
capabilities and anticipated utility of our GPS Cancer, including
predicting patient response and resistance to therapeutics,
enabling diagnoses by physicians and accelerating efforts to bring
novel combinations of therapeutic agents to cancer patients.
Forward-looking statements are subject to numerous risks and
uncertainties that could cause actual results to differ materially
from currently anticipated results. Factors that may cause future
results to differ materially from management’s current expectations
include, among other things, that GPS Cancer may not perform as
anticipated, that sufficient physicians may not adopt GPS Cancer to
assist their diagnoses or that healthcare payers may not provide
reimbursement for GPS Cancer as expected. Our business is subject
to numerous additional risks and uncertainties, including, among
others, risks relating to market acceptance of our products; our
ability to successfully launch new products and applications;
competition; our sales, marketing and distribution capabilities;
our planned sales, marketing, and research and development
activities; unanticipated increases in costs or expenses; and risks
associated with international operations. Information on these and
additional risks, uncertainties, and other information affecting
our business and operating results can be found in our existing and
future filings with the Securities and Exchange Commission. These
forward-looking statements speak only as of the date hereof. We
disclaim any obligation to update these forward-looking statements
except as may be required by law.
About NantHealth, Inc.
NantHealth, Inc., a member of the NantWorks ecosystem of
companies, is a next-generation, evidence-based, personalized
healthcare company enabling improved patient outcomes and more
effective treatment decisions for critical illnesses. NantHealth's
unique systems-based approach to personalized healthcare applies
novel diagnostics tailored to the specific molecular profiles of
patient tissues and integrates this molecular data in a clinical
setting with large-scale, real-time biometric signal and phenotypic
data to track patient outcomes and deliver precision medicine. For
nearly a decade, NantHealth has developed an adaptive learning
system, which includes its unique software, middleware and hardware
systems infrastructure that collects, indexes, analyzes and
interprets billions of molecular, clinical, operational and
financial data points derived from novel and traditional sources,
continuously improves decision-making and further optimizes our
clinical pathways and decision algorithms over time. For more
information please visit www.nanthealth.com and follow
Dr. Soon-Shiong on Twitter @DrPatSoonShiong.
1 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934668/
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171025005299/en/
NANTHEALTH MEDIA CONTACTJen
HodsonNantWorksjhodson@nantworks.com
NantHealth (NASDAQ:NH)
Historical Stock Chart
From Jun 2024 to Jul 2024
NantHealth (NASDAQ:NH)
Historical Stock Chart
From Jul 2023 to Jul 2024